[1]
2015. Adaptation of a human gut epithelial model in relation to the assessment of clinical pharmacokinetic parameters for selected tyrosine kinase inhibitors. ADMET and DMPK. 3, 1 (Mar. 2015), 51–67. DOI:https://doi.org/10.5599/admet.3.1.169.